Biofarma Group

Biofarma Group

Lyon, France· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Biofarma Group is a private, France-based biotech established in 2008, specializing in vaccines and biologics for infectious diseases. As a developer and manufacturer, it likely operates a hybrid business model combining proprietary R&D with contract services. While specific pipeline and financial details are not publicly disclosed, its strategic location in Lyon, a major European biopharma hub, positions it to serve significant public health markets, though it faces competition from large multinational vaccine producers.

Infectious Disease

Technology Platform

Inferred expertise in vaccine development and biologics manufacturing platforms; specific modalities not publicly disclosed.

Opportunities

Growing global focus on pandemic preparedness and vaccine supply chain resilience in Europe creates potential for funding and partnership opportunities.
The large and expanding market for vaccines and infectious disease biologics offers significant addressable demand for successful products.

Risk Factors

High R&D failure risk inherent in vaccine development and intense competition from large, established multinational pharmaceutical companies.
Financial sustainability is a concern for a private company without visible revenue streams or disclosed funding.

Competitive Landscape

Operates in a highly competitive market dominated by global giants like GSK, Sanofi, Pfizer, and Merck. Also competes with numerous biotech startups and CDMOs for talent, funding, and partnerships within the European biotech ecosystem.